Solid Biosciences Inc. (SLDB) insider trading

By person

28 insiders · 115 transactions

2.0×

Alexander Cumbo holds only 2.0 times base salary in stock. $1.32M of shares against $650.99K in salary for 2025.

Salary from the company's own proxy. The shares are what Alexander Cumbo last reported holding, valued at $5.62, the price Common Stock was last bought or sold at on the open market here, on 19 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Perceptive Advisors LLC entity

Director

$83.68M (6)

—

+$83.68M

25,246,091

23.54%

$141.88M

+577.2%

Ra Capital Management, L.p. entity

10% owner

$17.69M (2)

—

+$17.69M

15,772,503

14.71%

$88.64M

+82.6%

Rajeev M. Shah

Director

$16.00M (1)

—

+$16.00M

13,281,046

12.39%

$74.64M

+143.2%

Adam Koppel

Director

$4.80M (1)

—

+$4.80M

11,964,500

11.16%

$67.24M

+282.2%

Boxer Capital, LLC entity

10% owner

—

$4.45M (3)

−$4.45M

3,473,272

3.24%

$19.52M

−11.5%

Bain Capital Life Sciences Investors, LLC entity

10% owner

$4.03M (1)

—

+$4.03M

5,034,582

4.70%

$28.29M

+60.8%

Adage Capital Management, L.P. entity

10% owner

$1.91M (1)

—

+$1.91M

4,248,084

3.96%

$23.87M

+6.3%

Ilan Ganot

Director

—

$1.76M (21)

−$1.76M

1,002,539

0.9350%

$5.63M

+9.8%

Jorge Armando Quiroz

Chief Medical Officer

—

$1.26M (5)

−$1.26M

228,092

0.2127%

$1.28M

−15.0%

Alexander Cumbo

President and CEO

—

$1.12M (7) scheduled

−$1.12M

235,405

0.2195%

$1.32M

+2,259%

Joel Solomon Zev Schneider

Chief Operating Officer

—

$949.58K (8)

−$949.58K

236,270

0.2203%

$1.33M

+61.1%

Pedro Alvaro Amorrortu

Chief Operating Officer

—

$827.63K (6)

−$827.63K

158,046

0.1474%

$888.22K

−14.6%

David T Howton

Chief Operating Officer

—

$498.88K (7) scheduled

−$498.88K

105,077

0.0980%

$590.53K

—

Kevin Tan

CFO & Treasurer

—

$390.15K (7) scheduled

−$390.15K

99,422

0.0927%

$558.75K

+434.5%

Jessie Hanrahan

Chief Regulatory Officer

—

$348.91K (7) scheduled

−$348.91K

74,318

0.0693%

$417.67K

—

Gabriel Brooks

Chief Medical Officer

—

$337.39K (7) scheduled

−$337.39K

97,241

0.0907%

$546.49K

+623.3%

Matthew Bennett Arnold

Director

—

$310.39K (3)

−$310.39K

3,933,429

3.67%

$22.11M

+15.8%

Paul Herzich

Chief Technology Officer

—

$308.50K (7) scheduled

−$308.50K

72,638

0.0677%

$408.23K

+720.5%

Carl Ashley Morris

Chief Scientific Officer

—

$265.11K (7)

−$265.11K

19,760

0.0184%

$111.05K

—

Juan Andrey Zarur

Director

—

$83.54K (2)

−$83.54K

701,294

0.6540%

$3.94M

−1.1%

Jennifer Lynn Ziolkowski

CFO, Treasurer & Asst. Secy

—

$30.01K (2)

−$30.01K

335,636

0.3130%

$1.89M

+97.8%

Clare Kahn

Director

$18.37K (2)

—

+$18.37K

2,960

0.0028%

$16.64K

—

Jennifer Marlowe

CSO

—

$13.52K (1)

−$13.52K

6,998

0.0065%

$39.33K

—

Lynette Herscha

Chief Legal Officer

—

$12.44K (1)

−$12.44K

160,859

0.1500%

$904.03K

—

Gilad David Hayeem

10% owner

—

3,542,746

3.30%

$19.91M

−1.0%

Ian F Smith

Director

—

141,585

0.1320%

$795.71K

—

Martin I Freed

Director

—

53,763

0.0501%

$302.15K

—

Sukumar Nagendran

Director

—

34,258

0.0319%

$192.53K

+1,613%

Solid Biosciences Inc.

What the insiders did Net buying

By person